2-Hydroxypropyl-beta-cyclodextrin
"2-Hydroxypropyl-beta-cyclodextrin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivative of beta-cyclodextrin that is used as an excipient for steroid drugs and as a lipid chelator.
Descriptor ID |
D000073738
|
MeSH Number(s) |
D04.345.103.333.500 D09.301.915.400.375.333.500 D09.698.365.855.400.375.333.500
|
Concept/Terms |
2-Hydroxypropyl-beta-cyclodextrin- 2-Hydroxypropyl-beta-cyclodextrin
- 2 Hydroxypropyl beta cyclodextrin
- beta-Hydroxypropylcyclodextrin
- beta Hydroxypropylcyclodextrin
- HPbetaCD
- Hydroxypropyl Betadex
- Betadex, Hydroxypropyl
- HP-beta-CD
- 2 Hydroxypropyl-beta-cyclodextrin
- Hydroxypropyl-beta-cyclodextrin
- Hydroxypropyl beta cyclodextrin
|
Below are MeSH descriptors whose meaning is more general than "2-Hydroxypropyl-beta-cyclodextrin".
Below are MeSH descriptors whose meaning is more specific than "2-Hydroxypropyl-beta-cyclodextrin".
This graph shows the total number of publications written about "2-Hydroxypropyl-beta-cyclodextrin" by people in this website by year, and whether "2-Hydroxypropyl-beta-cyclodextrin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "2-Hydroxypropyl-beta-cyclodextrin" by people in Profiles.
-
Anti-hyperalgesic and anti-inflammatory effects of citral with ß-cyclodextrin and hydroxypropyl-ß-cyclodextrin inclusion complexes in animal models. Life Sci. 2019 Jul 15; 229:139-148.
-
HP-ß-CD Functionalized Fe3O4/CNPs-Based Theranostic Nanoplatform for pH/NIR Responsive Drug Release and MR/NIRFL Imaging-Guided Synergetic Chemo/Photothermal Therapy of Tumor. ACS Appl Mater Interfaces. 2018 Oct 10; 10(40):33867-33878.
-
Intracorneal melatonin delivery using 2-hydroxypropyl-ß-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2. Int J Pharm. 2017 Aug 30; 529(1-2):608-616.
-
Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics. Orphanet J Rare Dis. 2017 06 28; 12(1):120.